Eye Health Supplements Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032

Description

The Global Eye Health Supplements Market was valued at USD 2.6 billion in 2023 and is projected to grow at a 7.3% CAGR from 2024 to 2032. These supplements, containing essential nutrients like vitamins A, E, and C, zinc, zeaxanthin, lutein, and omega-3 fatty acids, aim to protect eyes from oxidative stress, improve vision, and reduce age-related conditions such as macular degeneration and dry eye syndrome. Rising eye disorders, including cataracts, refractive errors, AMD, and glaucoma, drive market growth. The WHO reported in 2023 that 2.2 billion people globally had vision impairment, with 1 billion affected by refractive errors and cataracts. This has increased the adoption of eye health supplements to support vision health. Additional growth factors include increased screen time, advancements in product delivery technologies, and a growing geriatric population.

The overall eye health supplements industry is classified based on the ingredient type, indication, formulation, distribution channel, and region.

The market segments include antioxidants, lutein and zeaxanthin, omega-3 fatty acids, flavonoids, alpha-lipoic acid, coenzyme Q10, astaxanthin, and others. The lutein and zeaxanthin segment is forecasted to reach USD 1.5 billion by 2032. Lutein and zeaxanthin filter harmful blue light, reducing digital eye strain and protecting the retina. These carotenoids are concentrated in the macula, protecting it from oxidative stress and potentially lowering AMD risk. They possess anti-inflammatory properties, reducing eye inflammation and supporting ocular health. Their antioxidant properties support long-term eye health, driving market growth.

By indication, the market includes cataracts, eyelid conjunctivitis, AMD, glaucoma, corneal support, eye fatigue, and others. The AMD segment accounted for USD 780.2 million in 2023. AMD affects the macula, crucial for sharp vision. Supplements with lutein, zeaxanthin, vitamins C and E, and zinc support macular health. Antioxidants neutralize free radicals, potentially slowing AMD progression. Anti-inflammatory supplements reduce retinal inflammation, supporting eye health and driving demand for AMD-related supplements.

The U.S. eye health supplements market is projected to reach USD 1.8 billion by 2032. The U.S. has a developed healthcare system with advanced research facilities, clinical trials, and FDA regulation, ensuring high-quality supplements. Increased awareness about eye health, driven by aging populations, high screen time, and preventive health focus, fuels demand for eye health supplements. Additionally, the growing prevalence of conditions such as age-related macular degeneration (AMD) and cataracts is further driving the need for supplements aimed at preserving vision. Furthermore, innovations in supplement formulations, including the incorporation of antioxidants and omega-3 fatty acids, are attracting health-conscious consumers.

Product Code: 11150

Chapter 1 Methodology and Scope

1.1 Market scope and definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates and calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Increasing prevalence of eye disorders
  - 3.2.1.2 Growth in active screen time
  - 3.2.1.3 Advancements in product delivery technologies
  - 3.2.1.4 Rising geriatric population
- 3.2.2 Industry pitfalls and challenges
  - 3.2.2.1 High costs associated with advanced supplements
  - 3.2.2.2 Potential side effects
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
- 3.5.1 Core technologies
- 3.5.2 Adjacent technologies
3.6 Pricing analysis, 2023
- 3.6.1 By region
- 3.6.2 By key player
3.7 Future market trends
3.8 Pipeline analysis
3.9 Porter's analysis
3.10 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Ingredient Type, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Lutein and zeaxanthin
5.3 Antioxidants
5.4 Omega-3 fatty acids
5.5 Coenzyme Q10
5.6 Flavonoids
5.7 Alpha-lipoic acid
5.8 Astaxanthin
5.9 Other ingredient types

Chapter 6 Market Estimates and Forecast, By Indication, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Age-related macular degeneration (AMD)
6.3 Cataract
6.4 Glaucoma
6.5 Eye fatigue
6.6 Corneal support
6.7 Eyelid conjunctivitis
6.8 Other indications

Chapter 7 Market Estimates and Forecast, By Formulations, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Tablet/capsule
7.3 Liquid
7.4 Gels
7.5 Gummies
7.6 Powder

Chapter 8 Market Estimates and Forecast, By Distribution Channel, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 Hospital pharmacy
8.3 Retail pharmacy
8.4 Online pharmacy

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

9.1 Key trends
9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Spain
- 9.3.5 Italy
- 9.3.6 Netherlands
- 9.3.7 Rest of Europe
9.4 Asia Pacific
- 9.4.1 China
- 9.4.2 Japan
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 South Korea
- 9.4.6 Rest of Asia Pacific
9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Argentina
- 9.5.4 Rest of Latin America
9.6 Middle East and Africa
- 9.6.1 South Africa
- 9.6.2 Saudi Arabia
- 9.6.3 UAE
- 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

10.1 Alcon Inc.
10.2 Alliance Pharma plc
10.3 Bausch Health Companies Inc.
10.4 Bluebonnet Nutrition
10.5 Basic Brands Inc.
10.6 Herbalife Ltd.
10.7 Healthy Origins USA
10.8 NusaPure
10.9 Nordic Naturals
10.10 Nestle S.A.
10.11 Nutrivein
10.12 Pfizer, Inc.
10.13 Prestige Consumer Healthcare Inc.
10.14 Vitabiotics Ltd.
10.15 ZeaVision LLC